Patents by Inventor Michael Riedy

Michael Riedy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230052343
    Abstract: Methods, systems, and computer programs are presented for executing a mission by an autonomous device to inspect an asset. One method includes an operation for obtaining a workflow. The workflow includes operations to be executed during a mission to be performed by a robot and a destination for sending data resulting from the mission. The method further includes an operation for generating a package after completion of the mission associated with the workflow. The package is self-contained and comprises information obtained during the mission that enables generation of results. The package comprises sensor information collected by one or more sensors, telemetry information obtained by the robot, information about assets associated with the mission, software version identifier for the package generation, and routing information for transmitting the package to the destination. The method further includes an operation for analyzing the information of the package to determine results for the mission.
    Type: Application
    Filed: August 9, 2021
    Publication date: February 16, 2023
    Inventors: Joshua Michael Riedy, Nicholas Anthony Zaccardi
  • Patent number: 6586175
    Abstract: Genetic polymorphisms are identified in the human UGT2B4, UGT2B7 and UGT2B15 genes that alter UGT2B activity. Nucleic acids comprising the polymorphic sequences are used to screen patients for altered metabolism for UGT2B substrates, potential drug-drug interactions, and adverse/side effects, as well as diseases that result from environmental or occupational exposure to toxins. The nucleic acids are used to establish animal, cell and in vitro models for drug metabolism.
    Type: Grant
    Filed: July 20, 1999
    Date of Patent: July 1, 2003
    Assignee: DNA Sciences Laboratories, Inc.
    Inventors: Margaret Galvin, Andrew Miller, Laura Penny, Michael Riedy
  • Publication number: 20030077629
    Abstract: Genetic polymorphisms are identified in the human UGT2B4, UGT2B7 and UGT2B15 genes that alter UGT2B activity. Nucleic acids comprising the polymorphic sequences are used to screen patients for altered metabolism for UGT2B substrates, potential drug-drug interactions, and adverse/side effects, as well as diseases that result from environmental or occupational exposure to toxins. The nucleic acids are used to establish animal, cell and in vitro models for drug metabolism.
    Type: Application
    Filed: July 24, 2002
    Publication date: April 24, 2003
    Applicant: DNA Sciences, Inc.
    Inventors: Margaret Galvin, Andrew Miller, Laura Penny, Michael Riedy